Elite Pharmaceuticals Inc (ELTP)

[sharkey1]

Other challenges await. In December, a federal appeals court sided against Moderna on a patent issue. That sets the stage for a possible legal battle involving Moderna and Arbutus Biopharma (ABUS), which holds the patents, and Roivant Sciences (ROIV), which has licensed them. The companies won't discuss possible future litigation. SVB Leerink analyst Dr. Mani Foroohar has estimated that any settlement Moderna might reach would likely include a "single-digit royalty on vaccine sales." A 3% royalty, he wrote, would cost Moderna about $330 million plus a share of royalties through 2029.

A bigger issue is a dispute last year between Moderna and the National Institutes of Health over credit for inventin

That Roivant gets around, this text is from barrons, under Moderna faces chalenges, came out today, didn't know ROIV was in this deep